I agree that this site is using cookies. You can find further informations here.
X
Darras, B.
420  results:
Search for persons X
?
1

P211 Intravenous and intrathecal onasemnogene abeparvovec g..:

Darras, B. ; Mercuri, E. ; Strauss, K....
Neuromuscular Disorders.  33 (2023)  - p. S87 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P230 Safety update: Risdiplam clinical trial program for sp..:

Baranello, G. ; Chiriboga, C. ; Servais, L....
Neuromuscular Disorders.  33 (2023)  - p. S92-S93 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P205 Impact of disease modifying treatment by three months ..:

McGrattan, K. ; Spoden, A. ; McGhee, H....
Neuromuscular Disorders.  33 (2023)  - p. S86 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P234 Effect of Apitegromab on pedi-cat and promis-fatigue q..:

Crawford, T. ; Darras, B. ; Day, J....
Neuromuscular Disorders.  33 (2023)  - p. S93-S94 , 2023
Link: https://doi.org/10.1016/..
 
?
5

CO108 Longitudinal Trends in Hospitalization Rates in Patie..:

Jiang, T. ; Darras, B. ; Youn, B....
Value in Health.  26 (2023)  6 - p. S34-S35 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P227 MANATEE: GYM329 (RO7204239) in combination with Risdip..:

Duong, T. ; Darras, B. ; Morrow, J....
Neuromuscular Disorders.  33 (2023)  - p. S92 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P224 Effect of apitegromab on motor function at 36 months i..:

Crawford, T. ; Darras, B. ; Day, J....
Neuromuscular Disorders.  33 (2023)  - p. S91 , 2023
Link: https://doi.org/10.1016/..
 
?
8

O.01 Correlating molecular genetic testing for rare genetic..:

Jayaraman, D. ; Genetti, C. ; Aykanat, A....
Neuromuscular Disorders.  32 (2022)  - p. S42 , 2022
Link: https://doi.org/10.1016/..
 
?
9

P.109 FIREFISH Parts 1 and 2: 36-month safety and efficacy ..:

Servais, L. ; Baranello, G. ; Boespflug-Tanguy, O....
Neuromuscular Disorders.  32 (2022)  - p. S88 , 2022
Link: https://doi.org/10.1016/..
 
?
10

FP.23 Bulbar function for patients with spinal muscular atr..:

McGrattan, K. ; Shell, R. ; Hurst-Davis, R....
Neuromuscular Disorders.  32 (2022)  - p. S85 , 2022
Link: https://doi.org/10.1016/..
 
?
11

P.100 Rationale/design of the phase 3b ASCEND study of inve..:

Darras, B. ; Hagenacker, T. ; Finkel, R....
Neuromuscular Disorders.  32 (2022)  - p. S86 , 2022
Link: https://doi.org/10.1016/..
 
?
12

VP.13 Updates on the development of the spinal muscular atr..:

Pasternak, A. ; Maczek, E. ; Fragala-Pinkham, M....
Neuromuscular Disorders.  32 (2022)  - p. S63 , 2022
Link: https://doi.org/10.1016/..
 
?
13

P.113 Safety update: Risdiplam clinical trial development p..:

Chiriboga, C. ; Servais, L. ; Baranello, G....
Neuromuscular Disorders.  32 (2022)  - p. S89 , 2022
Link: https://doi.org/10.1016/..
 
?
14

P.102 Apitegromab in SMA: An analysis of multiple efficacy ..:

Crawford, T. ; Darras, B. ; Day, J....
Neuromuscular Disorders.  32 (2022)  - p. S86-S87 , 2022
Link: https://doi.org/10.1016/..
 
?
15

FP.36 Genetic variants in DTNA cause a mild dominantly inhe..:

Nascimento, A. ; Bruels, C. ; Codina, A....
Neuromuscular Disorders.  32 (2022)  - p. S113 , 2022
Link: https://doi.org/10.1016/..
 
1-15